Highlighter is on. Drag to highlight text. Click a highlight to remove it.
ALL / Neurology

Epilepsy: treatment

Epilepsy: treatment

Most neurologists now start antiepileptics following a second epileptic seizure. NICE guidelines suggest starting antiepileptics after the first seizure if any of the following are present:
  • the patient has a neurological deficit
  • brain imaging shows a structural abnormality
  • the EEG shows unequivocal epileptic activity
  • the patient or their family or carers consider the risk of having a further seizure unacceptable


Safety considerations of specific drugs

The MHRA and NICE have strengthed their advice against sodium valproate use recently:


Valproate must not be started for the first time in people (male or female) younger than 55 years, unless 2 specialists independently consider and document that there is no other effective or tolerated treatment, or there are compelling reasons that the reproductive risks do not apply.

Topiramate should not be used in women and girls of childbearing potential unless conditions of the Pregnancy Prevention Programme are fulfilled.

Mechanism of action of common antiepileptics

Drug treatment according to the type of epilepsy

Generalised tonic-clonic seizures
  • lamotrigine or levetiracetam

Focal seizures
  • first line: lamotrigine or levetiracetam
  • second line: carbamazepine, oxcarbazepine or zonisamide

Absence seizures (Petit mal)
  • first line: ethosuximide
  • second line: lamotrigine or levetiracetam
  • carbamazepine may exacerbate absence seizures

Myoclonic seizures
  • first-line: levetiracetam
  • second line: lamotrigine

Tonic or atonic seizures
  • first-line: lamotrigine
  • second line: clobazam, rufinamide, or topiramate

+PassMedicine Notes
Most neurologists now start antiepileptics following a second epileptic seizure. NICE guidelines suggest starting antiepileptics after the first seizure if any of the following are present:
  • the patient has a neurological deficit
  • brain imaging shows a structural abnormality
  • the EEG shows unequivocal epileptic activity
  • the patient or their family or carers consider the risk of having a further seizure unacceptable

Safety considerations of specific drugs

The MHRA and NICE have strengthed their advice against sodium valproate use recently:

Valproate must not be started for the first time in people (male or female) younger than 55 years, unless 2 specialists independently consider and document that there is no other effective or tolerated treatment, or there are compelling reasons that the reproductive risks do not apply.

Topiramate should not be used in women and girls of childbearing potential unless conditions of the Pregnancy Prevention Programme are fulfilled.

Drug treatment according to the type of epilepsy

Generalised tonic-clonic seizures
  • lamotrigine or levetiracetam
Focal seizures
  • first line: lamotrigine or levetiracetam
  • second line: carbamazepine, oxcarbazepine or zonisamide
Absence seizures (Petit mal)
  • first line: ethosuximide
  • second line: lamotrigine or levetiracetam
  • carbamazepine may exacerbate absence seizures
Myoclonic seizures
  • first-line: levetiracetam
  • second line: lamotrigine
Tonic or atonic seizures
  • first-line: lamotrigine
  • second line: clobazam, rufinamide, or topiramate

Selecting first- and second-line ASMs by seizure type



Media
Antiepileptic drugs made easy
Speed Pharmacology - YouTube
👍 27 👎 4
Antiepileptic drugs made easy
Osmosis - YouTube
👍 27 👎 4
Pharmacology - Antiepileptics
YouTube
👍 9 👎 4
Pharmacology - Antiepileptics
YouTube
👍 9 👎 4
Links
NICE
👍 33👎 27
2022 Epilepsy guidelines
Royal College of Physicians
👍 21👎 29
2013 Modern management of epilepsy
Saved ✓

MEDIA